Coherus Oncology, Inc. (NASDAQ:CHRS) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
Coherus Oncology, Inc.'s stock currently trades at $2.06 with a market capitalization of $165.2M. The Healthcare company's stock moved following the disclosure.